SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
04-Jan-24 4:03 PM View: | Poseida Therapeutics, Inc. (PSTX) | 02-Jan-24 | Grant | 250,000 | -- | -- | 70% 356.84K to 606.84K | |
12-Apr-23 4:49 PM View: | Poseida Therapeutics, Inc. (PSTX) | 11-Apr-23 | Grant | 356,836 | -- | -- | 100% 0 to 356.84K | |
03-Mar-22 7:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-22 | Grant | 45,533 | -- | -- | 36% 125.88K to 171.41K | |
15-Jun-21 4:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 14-Jun-21 | Market Purchase | 32,333 | $14.57 | $471,065.00 | 35% 93.55K to 125.88K | < 1% |
15-Jun-21 4:02 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 11-Jun-21 | Market Purchase | 2,021 | $14.50 | $29,304.50 | 2% 91.53K to 93.55K | 1% |
20-May-21 4:29 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 18-May-21 | Market Sale (Planned) | 761 | $14.55 | $11,072.50 | (< 1%) 92.29K to 91.53K | 4% |
03-Mar-21 5:15 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-21 | Grant | 35,021 | -- | -- | 61% 57.27K to 92.29K | |
03-Mar-20 5:00 PM View: | Atara Biotherapeutics, Inc. (ATRA) | 01-Mar-20 | Grant | 55,000 | -- | -- | 100% 0 to 55.0K |